Market Tracker

05/23 5:16pm ET

Endo International PLC (NASDAQ:ENDP)

12.88
Delayed Data
As of 4:14pm ET
 +1.04 / +8.78%
Today’s Change
9.70
Today|||52-Week Range
24.93
-21.80%
Year-to-Date
Francis Chou Buys Pharmaceutical Stocks, Including Valeant
May 17 / GuruFocus News - Paid Partner Content
Endo (ENDP) Beats on Q1 Earnings, Reaffirms '17 Guidance
May 09 / Zacks.com - Paid Partner Content
3 Small Biotech Value Plays
May 17 / TheStreet.com - Paid Partner Content
Endo (ENDP) Q1 Earnings Beat Estimates, Revenues in Line
May 09 / Zacks.com - Paid Partner Content
BioDelivery (BDSI) Q1 Earnings Beat Estimates, Stock Gains
May 16 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close11.84
Today’s open11.80
Day’s range11.80 - 12.90
Volume8,917,621
Average volume (3 months)8,772,017
Market cap$2.7B
Dividend yield--
Data as of 4:14pm ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)-96.37%
Earnings growth (this year)-23.60%
Earnings growth (next 5 years)-4.80%
Revenue growth (last year)+22.69%
P/E ratioNM
Price/Sales0.91
Price/Book0.98

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...+0.76+0.71%
PBHPrestige Brands Hold...-0.17-0.34%
IRWDIronwood Pharmaceuti...+0.31+1.72%
SAGESAGE Therapeutics In...+0.53+0.79%
Data as of 4:01pm ET, 05/23/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$0.74
Annual revenue (last year)$4.0B
Annual profit (last year)-$3.3B
Net profit margin-80.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul V. Campanelli
Chief Operating Officer &
Executive Vice President
Terrance J. Coughlin
Corporate headquarters
Dublin, Dublin

Forecasts